Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol.13, no.1, pp.53-62, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 13 Issue: 1
- Publication Date: 2018
- Doi Number: 10.2215/cjn.04120417
- Journal Name: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.53-62
- Open Archive Collection: AVESIS Open Access Collection
- Hacettepe University Affiliated: Yes
Abstract
Background and objectives Steroid-resistant nephrotic syndrome overwhelmingly progresses to ESRD. More than 30 monogenic genes have been identified to cause steroid-resistant nephrotic syndrome. We previously detected causative mutations using targeted panel sequencing in 30% of patients with steroid-resistant nephrotic syndrome. Panel sequencing has a number of limitations when compared with whole exome sequencing. We employed whole exome sequencing to detect monogenic causes of steroid-resistant nephrotic syndrome in an international cohort of 300 families.